Abstract
Background: Numerous studies on seasonality of birth and schizophrenia risk have been published but it is uncertain whether, among those with schizophrenia, refractory illness exhibits any predilection for birth month. We hypothesized and examined whether a season of birth effect was present in patients with schizophrenia with a history of clozapine treatment. Method: Using record linkage with Danish registers, we examined patients with schizophrenia born between 1950 and 1970, and between 1995 and 2009 and Cox regression analysis was used to examine season of birth in relation to history of clozapine treatment. Results: In a study population corresponding to 60,062 person-years from 5328 individuals with schizophrenia of which 1223 (23%) received at least one clozapine prescription, birth in the autumn (September–November) was associated with clozapine treatment (HR = 1.24; 95% CI 1.07–1.46) when compared with birth in the spring (March–May). Conclusion: Although replication studies are needed, this is the first evidence from a nationwide study suggesting a possible season-associated risk of clozapine treatment in schizophrenia. The reasons for this relationship remain to be further investigated but might be partially explained by early exposures such as winter flu season and low vitamin D levels.
Acknowledgements
The study was supported financially by Sygekassernes Helsefond (Health Insurance Foundation) grant to Sørensen HJ.
Declaration of interest: J. Nielsen has received grants from H. Lundbeck, Pfizer and Chempaq for clinical trials and received speaking fees from Bristol-Myers Squibb, Astra Zeneca, Lundbeck, Janssen-Cilag and Eli-Lilly. Other authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
Contributors
J. Nielsen designed the study, L. Foldager performed the statistical analyses, H.J. Sørensen wrote the initial draft of manuscript, R. Røge, S.G. Pristed and J.T. Andersen contributed to writing the manuscript. All authors edited the final version of the manuscript.